key: cord-1044573-ngilvqpr
authors: Tang, Julian W.
title: SARS-CoV-2 and aerosols—Arguing over the evidence
date: 2020-12-04
journal: J Virol Methods
DOI: 10.1016/j.jviromet.2020.114033
sha: 76ecd308d99a8b50f89a44036bf6499e94a4b00f
doc_id: 1044573
cord_uid: ngilvqpr

This Commentary discusses various aspects around the controversial issue of SARSCoV-2 and aerosol transmission, highlighting certain counter arguments and explaining why they are invalid.

An article by Cheng et al. [1] on the effectiveness of universal masking in Hong Kong to control the spread of COVID-19 (coronavirus disease 2019) highlights the recent, very public change in guidance over the wearing of masks in public places by multiple agencies and countries. This runs in parallel with another, perhaps even larger ongoing debate -whether or not SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the cause of COVID-19, is transmitted via aerosols.

In this context, 'aerosols' mean fine droplets that can stay suspended in the air for long periods that are able to be carried over longer distances (greater than 2 m), but which can also transmit the virus over shorter distances (over 1 m or less). Traditionally, such fine droplets were classified to lie below a 5 µm diameter cut-off, but this is now considered to be only a relative threshold and much of the suspension and transport of such fine respiratory droplets (or 'microdroplets') will depend on the ambient airflow in each situation [2] .

Recent articles by various scientists, which have been covered extensively by various media, have highlighted the debate around this SARS-CoV-2 aerosol transmission issue -particularly with the WHO (World Health Organization) [3, 4] . The WHO have issued online guidance and tweets stating that SARS-CoV-2 is not airborne -except when certain so-called 'AGPs' (aerosol-generating procedures) are being performed. These are medical procedures, including bronchoscopy, intubation, nebulization, suctioning and tracheostomy [5] .

But surely are not the much more common, naturally produced human exhalations like breathing, talking, coughing, sneezing, laughing and singing also aerosol-generating procedures [1, 6] (Figure 1) ? If not, why not? Here the reasoning and interpretation of the evidence becomes much more subjective and unclear -and many people are confused.

One of the main arguments against the aerosol transmission of SARS-CoV-2 is an example of 'inaccurate comparison', i.e. comparing apples with oranges.

The argument goes that if SARS-CoV-2 was spread via these naturally produced human aerosols, we should be seeing many more COVID-19 cases -like we do with measles and chickenpox, which are recognised as airborne infections with R 0 values of 10-17 [7] . The R 0 or basic reproductive number is the number of secondary cases of a disease generated when a single index case arises in a population of uniformly distributed susceptible individuals. This has been discussed a lot in the press recently, especially in relation to when it might be safe to relax lockdown measures. If the R 0 is less than 1, then it means that the epidemic is being brought under control, but if greater than 1, it means that the epidemic is continuing to spread.

There are a couple of problems with this argument. Firstly, with measles and chickenpox, these are systemic infections that produce a very distinct febrile rash illness with very few asymptomatic or mildly symptomatic cases. Therefore, secondary cases of these infections (as generated by an index case) are very easy to detect, count and isolate. This is not the case with COVID-19, where there is substantial evidence with many reports of asymptomatic or mild illness that may be missed and not counted, making under-diagnosis a significant problem [8] . Various epidemiological models that have been developed during the COVID-19 pandemic have recognised and included this as an unknown and potentially rather large variable in their estimates [9] . Even serosurveys are likely underestimating the full extent of COVID-19 cases because it is emerging that many infected cases may not produce antibodies, those that do may not retain them for very long [8] , and the various serology assays (particularly the rapid tests) are of widely differing sensitivities [10].

Thus the R 0 value may be much larger than the currently accepted value of around 1.5-2.0, based on the numbers of confirmed COVID-19 cases.

Yet, even with a lower current R 0 value this does not exclude the short-range ('conversational') aerosol route of infection, which brings us to the second point. Those who are advocating the aerosol

The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

Recognition of aerosol transmission of infectious agents: a commentary

How can airborne transmission of COVID-19 indoors be minimised?

It is Time to Address Airborne Transmission of COVID-19

Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations

Qualitative real-time schlieren and shadowgraph imaging of human exhaled airflows: an aid to aerosol infection control

Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises